Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-173505
Filing Date
2015-05-06
Accepted
2015-05-06 10:00:21
Documents
12
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d912636d10q.htm 10-Q 368892
2 EX-10.1 d912636dex101.htm EX-10.1 253817
3 EX-31.1 d912636dex311.htm EX-31.1 5804
4 EX-31.2 d912636dex312.htm EX-31.2 5938
5 EX-32.1 d912636dex321.htm EX-32.1 3254
6 EX-32.2 d912636dex322.htm EX-32.2 3401
  Complete submission text file 0001193125-15-173505.txt   4496269

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT jnp-20150331.xml EX-101.INS 526936
8 XBRL TAXONOMY EXTENSION SCHEMA jnp-20150331.xsd EX-101.SCH 46303
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE jnp-20150331_cal.xml EX-101.CAL 72200
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE jnp-20150331_def.xml EX-101.DEF 147144
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE jnp-20150331_lab.xml EX-101.LAB 354331
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jnp-20150331_pre.xml EX-101.PRE 248394
Mailing Address 4 LIBERTY SQUARE 4TH FLOOR BOSTON MA 02109
Business Address 4 LIBERTY SQUARE 4TH FLOOR BOSTON MA 02109 973-486-8820
JUNIPER PHARMACEUTICALS INC (Filer) CIK: 0000821995 (see all company filings)

EIN.: 592758596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10352 | Film No.: 15835395
SIC: 2834 Pharmaceutical Preparations